Bromopotassium Commodity Market Dynamics Intelligence Analysis (May 27, 2026)

I. Recent Market Price Dynamics
1. Regional Price Disparities in China
- Hubei Province: RMB 21,500 per metric ton for 99.9% purity bromopotassium (data as of May 12, 2026; brand: Hubei Qiba Jiu Chemical Co., Ltd.)
- Shandong Province: RMB 22,000 per metric ton for 99% purity bromopotassium (data as of May 13, 2026; brand: Shandong Hongyang Chemical Co., Ltd.)
- Jiangsu Province: Significant price volatility—quoted range of RMB 5,300–66,000 per metric ton for 99% purity bromopotassium (April–May 2026 data; brand: Suzhou Shangma Chemical Co., Ltd.), likely attributable to variations in specifications or transaction terms resulting in extreme outliers.

2. Price Trend Analysis
- From early to mid-May 2026, the national average price remained stable at approximately RMB 22,000 per metric ton, representing a 22% decline from the April 2026 average price (RMB 28,200 per metric ton), primarily driven by increased supply capacity release and higher import volumes.
- Regional price spread: The ~RMB 500/ton difference between Shandong and Hubei reflects logistics costs and brand premium differentials.

II. Market Supply-Demand Landscape
1. Supply Side
- Domestic Capacity: China’s total bromopotassium production capacity reached 126,000 metric tons per year in 2025. Top-tier enterprises—including Shandong Haihua Group, Tianjin Changlu Haijing Group, and Jiangsu Anbang Electrochemical Co., Ltd.—collectively accounted for 68.4% of national capacity, indicating high regional concentration.
- Output Growth: Total output in 2025 amounted to 128,600 metric tons, a 20% YoY increase, largely attributable to technological upgrades and capacity expansions in Shandong, Jiangsu, and Zhejiang provinces.
- Import Dependence: In 2025, imports totaled 1,280 metric tons (a 5.9% YoY decline), with an average import price of RMB 47,600 per metric ton—significantly higher than the domestic average—indicating continued reliance on imported products for high-end applications.

2. Demand Side
- Downstream Applications:
- Optical Components: Growing demand from mid-infrared lasers and thermal imaging modules is driving demand for optical-grade bromopotassium.
- Photosensitive Materials: Demand in professional photography is projected at 2,850 metric tons in 2026 (a 12% YoY increase), with particularly strong growth observed in high-end artistic photography.
- Industrial Applications: Robust demand for brominated flame retardants—driven by printed circuit board (PCB) laminates, new-energy vehicles, and 5G base stations—is indirectly boosting bromine demand and consequently influencing the bromopotassium market.
- Regional Distribution: Shandong accounts for 40% of national output, leveraging its port infrastructure to serve both domestic and international markets; Jiangsu and Zhejiang together contribute 41%, forming three major production hubs nationwide.

III. Industry Drivers
1. Policy Support
- Bromopotassium has been included in China’s National Key-Supported Fine Chemical Products Catalogue. Stricter environmental regulations are accelerating enterprises’ green transformation—for example, wastewater treatment rates now exceed 98%, and slag comprehensive utilization rates surpass 90%.
- Under the “Infrared and Laser Optical Materials Industry Breakthrough Action Plan”, bromopotassium crystals have been designated as “bottleneck materials”, with dedicated subsidies and insurance policies supporting accelerated domestic substitution.

2. Technological Advancement
- Domestic product purity has reached ≥99.95%, and crystal morphology control precision has improved to the nanometer level—approaching international advanced standards.
- Leading enterprises have mastered continuous production processes, achieving a 30% improvement in production efficiency and shortening new product development cycles to just 12 months.

3. Industrial Chain Synergy
- Upstream Bromine Supply: China’s apparent bromine consumption reached 144,000 metric tons in 2025, with an import dependence of 52.78%. Rising global sulfur prices have pushed up bromine production costs, indirectly supporting bromopotassium pricing.
- Downstream Application Expansion: Emerging sectors—including zinc-bromine flow batteries and advanced semiconductor packaging—are creating incremental demand and opening new growth avenues.

IV. Risks and Challenges
1. Raw Material Price Volatility: High import dependence on bromine exposes bromopotassium producers to international price fluctuations, which may directly impact production costs.
2. Environmental Regulatory Pressure: Stringent environmental supervision may constrain production capacity at certain facilities, potentially intensifying supply tightness.
3. Technical Barriers: Production of optical-grade bromopotassium remains dominated by international firms; domestic enterprises must overcome challenges related to crystal growth and directional cutting technologies.

V. Outlook (2026–2027)
1. Price Trends
- Short Term (Second Half of 2026): Average price expected to remain stable within RMB 21,000–22,000 per metric ton, supported by balanced supply-demand conditions.
- Long Term (2027): Should emerging application demand materialize fully, prices may experience moderate upward pressure, reaching RMB 23,000–24,000 per metric ton.

2. Market Size
- China’s bromopotassium market size is projected to reach RMB 4.694 billion in 2026, representing a 7.9% YoY growth—slightly slower than the 8.3% growth recorded in 2025 but still outpacing the global average.
- The optical components segment shows exceptional growth: industry scale is expected to reach USD 159 million in 2026 (a 12% YoY increase), primarily fueled by rising demand for infrared lasers and thermal imaging modules.

3. Competitive Landscape
- The CR5 (combined market share of the top five domestic enterprises) is projected to rise from 63.4% in 2025 to 67.1% in 2026, as leading firms consolidate advantages through technological standard-setting and capacity expansion.
- Accelerated import substitution: Import dependence for pharmaceutical-grade bromopotassium has declined from 60% in 2020 to 40% in 2025, and is expected to decrease further in 2026.